Other Cancers OS Results for Atezolizumab + Platinum/Gemcitabine vs Placebo + plt/gem in 1L Treatment of mUC: IMvigor130 Study Jun 23, 2023
Other Cancers LBA23 - Pembrolizumab with chemotherapy vs. C alone for first-line (1L) advanced urothelial carcinoma: KEYNOTE-361 Jun 23, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Ripretinib vs Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial Jun 23, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Pembrolizumab Vs. Chemotherapy as First-Line Therapy in Individuals With NSCLC Jun 23, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durvalumab after Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC Jun 23, 2023
Other Cancers Antibiotic Use and Outcomes in Advanced Biliary Tract Cancer: TOPAZ-1 Study Analysis Jun 15, 2023
Other Cancers Oral Azacitidine in First Remission AML Patients After Intensive Chemotherapy Jun 15, 2023
Other Cancers Muscle-Invasive Urothelial Carcinoma: Adjuvant Atezolizumab Versus Observation (IMVIGOR010) Jun 15, 2023
